{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:30:55Z","timestamp":1787725855398,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008114","name":"Nanjing Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.canlet.2019.11.014","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T20:05:27Z","timestamp":1573848327000},"page":"481-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"special_numbering":"C","title":["FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK\/mTOR-mediated autophagy"],"prefix":"10.1016","volume":"469","author":[{"given":"Jian-zhong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang-yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-geng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.11.014_bib1","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2019.11.014_bib2","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.7150\/ijbs.11439","article-title":"Insights into chemoresistance of prostate cancer","volume":"11","author":"Zhang","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2019.11.014_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2016.05.002","article-title":"Docetaxel activity in the era of life-prolonging hormonal therapies for metastatic castration-resistant prostate cancer","volume":"70","author":"Francini","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.canlet.2019.11.014_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.canlet.2019.11.014_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2007.05.021","article-title":"Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion","volume":"130","author":"Nakatogawa","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.11.014_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1080\/15548627.2017.1388476","article-title":"MTA1 is a novel regulator of autophagy that induces tamoxifen resistance in breast cancer cells","volume":"14","author":"Lee","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2019.11.014_bib7","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.3748\/wjg.v24.i41.4643","article-title":"Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma","volume":"24","author":"Huang","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2019.11.014_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrclinonc.2016.183","article-title":"Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy","volume":"14","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.11.014_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.canlet.2017.12.013","article-title":"Docetaxel-mediated autophagy promotes chemoresistance in castration-resistant prostate cancer cells by inhibiting STAT3","volume":"416","author":"Hu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2019.11.014_bib10","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.21873\/anticanres.13735","article-title":"Low-dose docetaxel enhanced the anticancer effect of temsirolimus by overcoming autophagy in prostate cancer cells","volume":"39","author":"Inamura","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2019.11.014_bib11","first-page":"11","article-title":"Fenofibrate augments the sensitivity of drug-resistant prostate cancer cells to docetaxel","author":"Luty","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2019.11.014_bib12","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1158\/0008-5472.CAN-16-3566","article-title":"FOXM1 in cancer: interactions and vulnerabilities","volume":"77","author":"Gartel","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.014_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12957-018-1352-3","article-title":"Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer","volume":"16","author":"Pan","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2019.11.014_bib14","doi-asserted-by":"crossref","first-page":"17027","DOI":"10.18632\/oncotarget.15224","article-title":"FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.014_bib15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/abbs\/gmw072","article-title":"FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK\/mitochondrial pathway","volume":"48","author":"Wang","year":"2016","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2019.11.014_bib16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/onc.2015.152","article-title":"Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance","volume":"35","author":"Khongkow","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.11.014_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1479-5876-11-204","article-title":"Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel","volume":"11","author":"Li","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.canlet.2019.11.014_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/br.2017.915","article-title":"Downregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell line","volume":"7","author":"Zhong","year":"2017","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.canlet.2019.11.014_bib19","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.18632\/oncotarget.23513","article-title":"MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K\/Akt\/mTOR pathway","volume":"9","author":"Tian","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.014_bib20","doi-asserted-by":"crossref","first-page":"41064","DOI":"10.18632\/oncotarget.17026","article-title":"Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer","volume":"8","author":"Lin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.014_bib21","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3390\/ijms18051088","article-title":"Inhibition of autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K\/AKT\/mTOR and ERK\/p38 MAPK-dependent signaling in human prostate cancer cells","volume":"18","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2019.11.014_bib22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrurol.2014.196","article-title":"Autophagy as a modulator and target in prostate cancer","volume":"11","author":"Farrow","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.canlet.2019.11.014_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3892\/or.2015.4331","article-title":"Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK\/mTOR pathway in prostate cancer","volume":"35","author":"Liao","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2019.11.014_bib24","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1809681115","article-title":"FSIP1 regulates autophagy in breast cancer","volume":"115","author":"Liu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2019.11.014_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ijsu.2018.06.010","article-title":"The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: a network meta-analysis","volume":"56","author":"Song","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.canlet.2019.11.014_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3892\/ijo.2017.4094","article-title":"FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis","volume":"51","author":"Chen","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.11.014_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7150\/jca.28099","article-title":"High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer","volume":"10","author":"Kim","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2019.11.014_bib28","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.18632\/aging.101706","article-title":"Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma","volume":"10","author":"Liu","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.canlet.2019.11.014_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11010-015-2651-4","article-title":"Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt\/beta-catenin signaling pathway in cervical cancer","volume":"413","author":"Wang","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.canlet.2019.11.014_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-017-0536-y","article-title":"FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients","volume":"36","author":"Tassi","year":"2017","journal-title":"J. Exp. Clin. Cancer Res. : CR (Clim. Res.)"},{"key":"10.1016\/j.canlet.2019.11.014_bib31","first-page":"26884","article-title":"TNFAIP8 promotes prostate cancer cell survival by inducing autophagy","volume":"9","author":"Niture","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2019.11.014_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41419-017-0043-2","article-title":"Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields","volume":"9","author":"Martin-Sanchez","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2019.11.014_bib33","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/bjc.2015.17","article-title":"Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy","volume":"112","author":"Tan","year":"2015","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.canlet.2019.11.014_bib34","first-page":"1683","article-title":"Geraniol induces cooperative interaction of apoptosis and autophagy to elicit cell death in PC-3 prostate cancer cells","volume":"40","author":"Kim","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.11.014_bib35","doi-asserted-by":"crossref","first-page":"86277","DOI":"10.18632\/oncotarget.21138","article-title":"Salen-Mn compounds induces cell apoptosis in human prostate cancer cells through promoting AMPK activity and cell autophagy","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.11.014_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41419-018-0866-5","article-title":"Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells","volume":"9","author":"Cristofani","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2019.11.014_bib37","doi-asserted-by":"crossref","DOI":"10.1186\/1476-4598-10-126","article-title":"Characterisation and manipulation of docetaxel resistant prostate cancer cell lines","volume":"10","author":"O'Neill","year":"2011","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2019.11.014_bib38","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1634\/theoncologist.2018-0621","article-title":"Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): phase II trial of high dose pantoprazole (autophagy inhibitor) with docetaxel in metastatic castration-resistant prostate cancer (mCRPC)","volume":"24","author":"Hansen","year":"2019","journal-title":"The Oncologist"},{"key":"10.1016\/j.canlet.2019.11.014_bib39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00109-019-01750-8","article-title":"FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells","volume":"97","author":"Hamurcu","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.canlet.2019.11.014_bib40","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1080\/15384101.2017.1356507","article-title":"Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death","volume":"16","author":"Guo","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2019.11.014_bib41","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.7150\/thno.33282","article-title":"KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy","volume":"9","author":"Jia","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2019.11.014_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7150\/thno.20356","article-title":"PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1\/AMPK-mediated autophagy","volume":"8","author":"Zeng","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2019.11.014_bib43","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1111\/cas.13808","article-title":"Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK\/mTOR signaling pathway","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2019.11.014_bib44","first-page":"1601","article-title":"alpha-hederin induces autophagic cell death in colorectal cancer cells through reactive oxygen species dependent AMPK\/mTOR signaling pathway activation","volume":"54","author":"Sun","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2019.11.014_bib45","doi-asserted-by":"crossref","first-page":"39806","DOI":"10.18632\/oncotarget.5655","article-title":"Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK\/mTOR signaling pathway and the interplay with Chk2 activation","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:51:32Z","timestamp":1759593092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519305695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":45,"alternative-id":["S0304383519305695"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.014","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK\/mTOR-mediated autophagy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}